Bone Biologics Corp
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
BBLG$0.33+3.0%Stored close · as of Nov 6, 2026
Contents
Item 2. Properties
We lease our primary office, which is located at 2 Burlington Woods Drive, Ste 100, Burlington, MA 01803, on a month to month lease.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.